Monoket (Isosorbide 5 Mononitrate)

Isosorbide 5-Mononitrate, the active ingredient in Monoket, is a nitrate vasodilator presented as an oral dosage form for oral use. It is employed to relieve angina pectoris and to improve exercise tolerance in patients with chronic stable angina. GNH USA supplies Monoket as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Monoket, a nitrate vasodilator, is used in the management of coronary artery disease‑related chest pain. - Angina pectoris: reduces the frequency and severity of acute chest pain episodes. - Chronic stable angina: improves exercise capacity and delays onset of pain during exertion. - Prophylaxis of angina attacks: provides long‑term prevention of anginal symptoms in patients with established coronary disease.

Isosorbide 5‑Mononitrate may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects: - Headache: throbbing or pressure‑type pain, often occurring after the first dose. - Dizziness or light‑headedness, especially when standing quickly. - Flushing: warm sensation and reddening of the skin. - Hypotension: mild drop in blood pressure causing fatigue. - Nausea or mild gastrointestinal upset. - Palpitations: awareness of heartbeat irregularities.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure leading to fainting. - Syncope: sudden loss of consciousness. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Methemoglobinemia: rare blood disorder causing cyanosis. - Myocardial infarction: extremely rare but reported in susceptible individuals.

Before initiating therapy, clinicians should evaluate cardiovascular status and consider potential interactions. - Assess cardiovascular stability: ensure patient is not hypotensive before dosing. - Monitor blood pressure: check regularly, especially after dose adjustments. - Avoid concurrent nitrates: combined use can cause profound hypotension. - Caution with PDE5 inhibitors: increased risk of severe blood pressure fall. - Adjust in renal impairment: dose may need modification in severe kidney disease. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Isosorbide 5‑Mononitrate can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Other nitrates (e.g., nitroglycerin): additive vasodilatory effect leading to dangerous hypotension. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil): risk of severe blood pressure reduction. - Guanylate cyclase stimulators (e.g., riociguat): synergistic vasodilation.

Moderate Interactions (Monitor Closely): - Antihypertensive agents (beta‑blockers, ACE inhibitors): may enhance blood‑pressure‑lowering effect. - Diuretics: can increase orthostatic hypotension. - Alcohol: additive vasodilatory effect, may worsen dizziness. - Smoking: induces metabolism, potentially reducing drug efficacy.